Abstract
Purpose of review
Pulmonary vein stenosis (PVS) is an increasingly recognized disease in infants and young children. Controversy exists regarding the best management of this disease. The hallmarks of PVS include recurrence, upstream progression, and spread to previously unaffected pulmonary veins. This review highlights invasive and medical therapies for pediatric patients with primary and secondary PVS.
Recent findings
Catheter-based therapies for PVS are the mainstay of anatomic, large-vessel therapy. Angioplasty and stenting both have a role in the anatomic management of PVS. Repeated transcatheter interventions have been shown to improve survival. Surgical PVS intervention is an important element to PVS therapy. Primary (medical) therapy is increasingly recognized as an important element to PVS treatment. New anti-proliferative therapies have proven to be a useful adjunct to invasive therapies.
Summary
Congenital and acquired PVS are progressive diseases that pose a growing challenge for cardiologists. Surgical and transcatheter interventions in most cases have early success but are only temporizing solutions in the face of myofibroblastic proliferation. More recent studies focusing on benefits of immunomodulatory therapy have paved the way for the use of primary treatment alongside the anatomic therapy.
Similar content being viewed by others
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Pazos-Lopez P, Garcia-Rodriguez C, Guitian-Gonzalez A, et al. Pulmonary vein stenosis: etiology, diagnosis and management. World J Cardiol. 2016;8:81–8.
Caldarone CA, Najm HK, Kadletz M, Smallhorn JF, Freedom RM, Williams WG, et al. Relentless pulmonary vein stenosis after repair of total anomalous pulmonary venous drainage. Ann Thorac Surg. 1998;66:1514–20.
Hancock Friesen CL, Zurakowski D, Thiagarajan RR, Forbess JM, del Nido PJ, Mayer JE, et al. Total anomalous pulmonary venous connection: an analysis of current management strategies in a single institution. Ann Thorac Surg. 2005;79:596–606 discussion 596-606.
DiLorenzo MP, Santo A, Rome JJ, et al. Pulmonary vein stenosis: outcomes in children with congenital heart disease and prematurity. Semin Thorac Cardiovasc Surg. 2019;31:266–73.
Riedlinger WF, Juraszek AL, Jenkins KJ, et al. Pulmonary vein stenosis: expression of receptor tyrosine kinases by lesional cells. Cardiovasc Pathol. 2006;15:91–9.
Balasubramanian S, Rehman M, Gauvreau K, Jenkins KJ. Bilateral disease and early age at presentation are associated with shorter survival in patients with congenital heart disease and intraluminal pulmonary vein stenosis. Congenit Heart Dis. 2012;7:378–86.
•• Cory MJ, Ooi YK, Kelleman MS, Vincent RN, Kim DW, Petit CJ. Reintervention is associated with improved survival in pediatric patients with pulmonary vein stenosis. JACC Cardiovasc Interv. 2017;10:1788–98 First study to demonstrate the significant impact of reintervention and frequent surveillance on patient survival and vein patency in pediatric pulmonary vein stenosis patients.
Drossner DM, Kim DW, Maher KO, Mahle WT. Pulmonary vein stenosis: prematurity and associated conditions. Pediatrics. 2008;122:e656–e61.
Roman KS, Kellenberger CJ, Macgowan CK, Coles J, Redington AN, Benson LN, et al. How is pulmonary arterial blood flow affected by pulmonary venous obstruction in children? A phase-contrast magnetic resonance study. Pediatr Radiol. 2005;35:580–6.
Ghoshhajra BB, Lee AM, Engel LC, Celeng C, Kalra MK, Brady TJ, et al. Radiation dose reduction in pediatric cardiac computed tomography: experience from a tertiary medical center. Pediatr Cardiol. 2014;35:171–9.
Gorlin R, Gorlin SG. Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. I Am Heart J. 1951;41:1–29.
Pacifico AD, Mandke NV, McGrath LB, Colvin EV, Bini RM, Bargeron LM Jr. Repair of congenital pulmonary venous stenosis with living autologous atrial tissue. J Thorac Cardiovasc Surg. 1985;89:604–9.
Lo Rito M, Gazzaz T, Wilder T, Saedi A, Chetan D, van Arsdell GS, et al. Repair type influences mode of pulmonary vein stenosis in total anomalous pulmonary venous drainage. Ann Thorac Surg. 2015;100:654–62.
Kalfa D, Belli E, Bacha E, et al. Outcomes and prognostic factors for postsurgical pulmonary vein stenosis in the current era. J Thorac Cardiovasc Surg. 2018;156:278–86.
Lacour-Gayet F, Zoghbi J, Serraf AE, Belli E, Piot D, Rey C, et al. Surgical management of progressive pulmonary venous obstruction after repair of total anomalous pulmonary venous connection. J Thorac Cardiovasc Surg. 1999;117:679–87.
Devaney EJ, Ohye RG, Bove EL. Pulmonary vein stenosis following repair of total anomalous pulmonary venous connection. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2006;9:51–5.
Alsoufi B, Cai S, Van Arsdell GS, Williams WG, Caldarone CA, Coles JG. Outcomes after surgical treatment of children with partial anomalous pulmonary venous connection. Ann Thorac Surg. 2007;84:2020–6 discussion 2020-6.
Quinonez LG, Gauvreau K, Borisuk M, Ireland C, Marshall AM, Mayer JE, et al. Outcomes of surgery for young children with multivessel pulmonary vein stenosis. J Thorac Cardiovasc Surg. 2015;150:911–7.
Rosenblum JM, Altin HF, Gillespie SE, et al. Management outcomes of primary pulmonary vein stenosis. J Thorac Cardiovasc Surg. 2020;159:1029–1036 e1.
McMahon CJ, Mullins CE, El Said HG. Intrastent sonotherapy in pulmonary vein restenosis: a new treatment for a recalcitrant problem. Heart. 2003;89:E6.
Peng LF, Lock JE, Nugent AW, Jenkins KJ, McElhinney DB. Comparison of conventional and cutting balloon angioplasty for congenital and postoperative pulmonary vein stenosis in infants and young children. Catheter Cardiovasc Interv. 2010;75:1084–90.
Bingler MA, Darst JR, Fagan TE. Cryo-balloon angioplasty for pulmonary vein stenosis in pediatric patients. Pediatr Cardiol. 2012;33:109–14.
Driscoll DJ, Hesslein PS, Mullins CE. Congenital stenosis of individual pulmonary veins: clinical spectrum and unsuccessful treatment by transvenous balloon dilation. Am J Cardiol. 1982;49:1767–72.
Seale AN, Daubeney PE, Magee AG, Rigby ML. Pulmonary vein stenosis: initial experience with cutting balloon angioplasty. Heart. 2006;92:815–20.
Mueller GC, Dodge-Khatami A, Weil J. First experience with a new drug-eluting balloon for the treatment of congenital pulmonary vein stenosis in a neonate. Cardiol Young. 2010;20:455–8.
Shaffer KM, Mullins CE, Grifka RG, O’Laughlin MP, McMahon W, Ing FF, et al. Intravascular stents in congenital heart disease: short- and long-term results from a large single-center experience. J Am Coll Cardiol. 1998;31:661–7.
Xi T, Gao R, Xu B, Chen L, Luo T, Liu J, et al. In vitro and in vivo changes to PLGA/sirolimus coating on drug eluting stents. Biomaterials. 2010;31:5151–8.
Khan A, Qureshi AM, Justino H. Comparison of drug eluting versus bare metal stents for pulmonary vein stenosis in childhood. Catheter Cardiovasc Interv. 2019;94:233–42.
Balasubramanian S, Marshall AC, Gauvreau K, Peng LF, Nugent AW, Lock JE, et al. Outcomes after stent implantation for the treatment of congenital and postoperative pulmonary vein stenosis in children. Circ Cardiovasc Interv. 2012;5:109–17.
Chen HY, Hermiller J, Sinha AK, Sturek M, Zhu L, Kassab GS. Effects of stent sizing on endothelial and vessel wall stress: potential mechanisms for in-stent restenosis. J Appl Physiol (1985). 2009;106:1686–91.
Zamora CA, Sugimoto K, Yamaguchi M, Sugimura K. Effect of stent oversizing on in-stent stenosis and lumen size in normal porcine veins. J Endovasc Ther. 2005;12:495–502.
Walsh A, Canny G, McMahon CJ, Redmond JM, McNally P. Hemoptysis from bronchial varices associated with pulmonary vein stenosis: role of surgical repair. Pediatr Pulmonol. 2013;48:838–40.
Bharat A, Epstein DJ, Grady M, Faro A, Michelson P, Sweet SC, et al. Lung transplant is a viable treatment option for patients with congenital and acquired pulmonary vein stenosis. J Heart Lung Transplant. 2013;32:621–5.
Kato H, Fu YY, Zhu J, Wang L, Aafaqi S, Rahkonen O, et al. Pulmonary vein stenosis and the pathophysiology of “upstream” pulmonary veins. J Thorac Cardiovasc Surg. 2014;148:245–53.
Zhu J, Ide H, Fu YY, Teichert AM, Kato H, Weisel RD, et al. Losartan ameliorates “upstream” pulmonary vein vasculopathy in a piglet model of pulmonary vein stenosis. J Thorac Cardiovasc Surg. 2014;148:2550–7.
Rehman M, Jenkins KJ, Juraszek AL, Connor JA, Gauvreau K, Muneeb M, et al. A prospective phase II trial of vinblastine and methotrexate in multivessel intraluminal pulmonary vein stenosis in infants and children. Congenit Heart Dis. 2011;6:608–23.
•• Callahan R, Kieran MW, Baird CW, et al. Adjunct targeted biologic inhibition agents to treat aggressive multivessel intraluminal pediatric pulmonary vein stenosis. J Pediatr. 2018;198:29–35 e5 First and only prospective study to demonstrate the benefits of primary (medical) therapy in children with multivessel pulmonary vein stenosis.
Bromberg-Marin G, Tsimikas S, Mahmud E. Treatment of recurrent pulmonary vein stenoses with endovascular stenting and adjuvant oral sirolimus. Catheter Cardiovasc Interv. 2007;69:362–8.
Hallbergson A, Esch JJ, Tran TX, Lock JE, Marshall AC. Systemic rapamycin to prevent in-stent stenosis in peripheral pulmonary arterial disease: early clinical experience. Cardiol Young. 2016;26:1319–26.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Cardiology/CT Surgery
Rights and permissions
About this article
Cite this article
Patel, J.D., Briones, M., Jones, S. et al. Medical and Invasive Management of Congenital and Acquired Pulmonary Vein Stenosis. Curr Treat Options Peds 6, 170–181 (2020). https://doi.org/10.1007/s40746-020-00198-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40746-020-00198-0